Argovit™ Silver Nanoparticles Mitigate Sodium Arsenite-Induced Cytogenotoxicity Effects in Cultured Human Lymphocytes; Toxics; Vol. 13, iss. 7

Bibliographische Detailangaben
Parent link:Toxics.— .— Basel: MDPI AG
Vol. 13, iss. 7.— 2025.— Article number 539, 17 p.
Weitere Verfasser: del Carmen Jauregui R. M. Romo Maria, Ruiz-Ruiz B. Balam, Casilias-Figueroa F. Francisco, Guadalupe Giron V. N. Vazquez Nayeli, Roberto Luna V. G. Vazquez Gomez, Torres-Bugarin O. Olivia, Castaneda-Yslas I. Ya. Idalia Yazmin, Pestryakov A. N. Aleksey Nikolaevich, Bogdanchikova N. Nina, Arellano-Garcia M. E. Maria Evarista
Zusammenfassung:Title screen
Exposure to arsenic, a known environmental and occupational genotoxicant, poses significant health risks. Identifying agents capable of mitigating its effects is crucial for public health. This study evaluates the protective potential of Argovit™ silver nanoparticles (AgNPs) against cytotoxic and genotoxic damage induced by sodium arsenite in ex vivo cultured human lymphocytes obtained from the whole blood of healthy donors. Lymphocytes were exposed to sodium arsenite (3.7 × 10−3 µg/mL) and Argovit™ AgNPs (3.6 × 10−3 µg/mL). The cytokinesis-block micronucleus (CBMN) assay was performed using a modified 144 h protocol to assess delayed effects across two cell cycles. Four groups were analyzed: untreated control, sodium arsenite only, AgNPs only, and sodium arsenite followed by AgNPs. Arsenite exposure increased cytotoxic and genotoxic biomarkers. In contrast, post-treatment with AgNPs significantly reduced these effects. All treatments were performed in duplicate, and data were analyzed using the Kruskal–Wallis test with Dunn’s post hoc comparison (p < 0.05). Statistical analysis confirmed the antigenotoxic and cytoprotective properties of Argovit™. These findings support its potential application as a mitigating agent in scenarios of environmental or occupational exposure to genotoxic compounds
Текстовый файл
Sprache:Englisch
Veröffentlicht: 2025
Schlagworte:
Online-Zugang:https://doi.org/10.3390/toxics13070539
Format: Elektronisch Buchkapitel
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=681220

MARC

LEADER 00000naa0a2200000 4500
001 681220
005 20250818154929.0
090 |a 681220 
100 |a 20250818d2025 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Argovit™ Silver Nanoparticles Mitigate Sodium Arsenite-Induced Cytogenotoxicity Effects in Cultured Human Lymphocytes  |f Maria del Carmen Jauregui Romo, Balam Ruiz Ruiz, Francisco Casilas-Figueroa [et al.] 
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 71 tit 
330 |a Exposure to arsenic, a known environmental and occupational genotoxicant, poses significant health risks. Identifying agents capable of mitigating its effects is crucial for public health. This study evaluates the protective potential of Argovit™ silver nanoparticles (AgNPs) against cytotoxic and genotoxic damage induced by sodium arsenite in ex vivo cultured human lymphocytes obtained from the whole blood of healthy donors. Lymphocytes were exposed to sodium arsenite (3.7 × 10−3 µg/mL) and Argovit™ AgNPs (3.6 × 10−3 µg/mL). The cytokinesis-block micronucleus (CBMN) assay was performed using a modified 144 h protocol to assess delayed effects across two cell cycles. Four groups were analyzed: untreated control, sodium arsenite only, AgNPs only, and sodium arsenite followed by AgNPs. Arsenite exposure increased cytotoxic and genotoxic biomarkers. In contrast, post-treatment with AgNPs significantly reduced these effects. All treatments were performed in duplicate, and data were analyzed using the Kruskal–Wallis test with Dunn’s post hoc comparison (p < 0.05). Statistical analysis confirmed the antigenotoxic and cytoprotective properties of Argovit™. These findings support its potential application as a mitigating agent in scenarios of environmental or occupational exposure to genotoxic compounds 
336 |a Текстовый файл 
461 1 |t Toxics  |c Basel  |n MDPI AG 
463 1 |t Vol. 13, iss. 7  |v Article number 539, 17 p.  |d 2025 
610 1 |a cytotogenotoxicity 
610 1 |a lymphocytes culture 
610 1 |a silver nanoparticles 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
701 1 |a del Carmen Jauregui  |b R. M.  |g Romo Maria 
701 1 |a Ruiz-Ruiz  |b B.  |g Balam 
701 1 |a Casilias-Figueroa  |b F.  |g Francisco 
701 1 |a Guadalupe Giron  |b V. N.  |g Vazquez Nayeli 
701 1 |a Roberto Luna  |b V. G.  |g Vazquez Gomez 
701 1 |a Torres-Bugarin  |b O.  |g Olivia 
701 1 |a Castaneda-Yslas  |b I. Ya.  |g Idalia Yazmin 
701 1 |a Pestryakov  |b A. N.  |c Chemist  |c Professor of Tomsk Polytechnic University, Doctor of Chemical Science  |f 1963-  |g Aleksey Nikolaevich  |9 14796 
701 1 |a Bogdanchikova  |b N.  |g Nina 
701 1 |a Arellano-Garcia  |b M. E.  |g Maria Evarista 
801 0 |a RU  |b 63413507  |c 20250818 
850 |a 63413507 
856 4 |u https://doi.org/10.3390/toxics13070539  |z https://doi.org/10.3390/toxics13070539 
942 |c CF